Global Serological Testing Market OverviewThe global serological testing market is projected to grow at a compound annual growth rate (CAGR) of approximately 6–8% through 2027. Market expansion is ...

In the scurry to track, isolate and otherwise beat back the global coronavirus pandemic, testing people for traces of SARS-CoV-2, the virus that causes COVID-19, is a high priority. But a different ...

As more and more COVID-19 data are collected, the clearer our picture of the novel disease becomes. One of the most important pieces of the puzzle (though we stress that it is nevertheless only one ...

Scientists are starting to roll out new blood tests for the coronavirus, a key development that, unlike the current diagnostic tests, will help pinpoint people who are immune and reveal the full scope ...

Molecular test, or nucleic acid amplification, has been recommended by the FDA for the diagnosis of the COVID-19 virus. Nucleic acid amplification testing necessitates the collection of respiratory ...

The FDA has warned COVID-19 serological test-makers not to overstate the usefulness – or claim federal approval – of their products, cautioning that it may still be too early for such diagnostics to ...

The FDA has approved a blood test that will determine whether a person has been infected by COVID-19, the agency said Thursday morning. “We’re going to announce today, our first approval of a serology ...

Maureen Ferran is an associate professor of biology at Rochester Institute of Technology. This story originally featured on The Conversation. Widespread testing for the SARS-CoV-2 virus is important ...

At the root of almost every plan to restart society is a new kind of coronavirus test that searches not for the virus itself, but the remnants floating in people’s blood of the battle between their ...

In a recent study under consideration at Scientific Reports and posted to the Research Square* preprint server, researchers evaluated the impact of time on the sensitivity of four severe acute ...

Washington — Tests to detect antibodies in people who have previously been infected by the coronavirus must be covered free of charge under health insurance plans and Medicaid, according to new ...